What does a negative LDL cholesterol result indicate, and how should it be evaluated and managed?

Negative LDL Cholesterol: Interpretation and Management

A negative LDL cholesterol result is a nonsensical calculation error that indicates the LDL-C is too low to be accurately estimated by the equation used, and laboratories should report these values with a lower limit rather than as negative numbers. 1

What Causes Negative LDL Values

Negative LDL-C values arise from calculation errors when using the Friedewald equation, particularly in patients with:

• Very low actual LDL-C levels (< 0.50 mmol/L or < 20 mg/dL)
• Elevated triglycerides
• Nonfasting samples

The Friedewald equation systematically underestimates LDL-C in these scenarios, sometimes producing mathematically impossible negative values 1.

How to Properly Evaluate

Switch to the NIH equation immediately - this is the 2022 Canadian guideline recommendation that supersedes Friedewald 1. The NIH equation:

• Produces significantly fewer nonsensical negative values
• Maintains accuracy down to 0.50 mmol/L (approximately 20 mg/dL)
• Works with triglycerides up to 9.04 mmol/L (800 mg/dL)
• Has been validated against β-quantification in over 8,500 subjects

When you encounter a negative or extremely low calculated LDL-C:

1. Verify the calculation method - If Friedewald was used, recalculate using the NIH equation 1

2. Check for laboratory interference - Monoclonal paraproteins (multiple myeloma, IgG gammopathy) can cause falsely low direct LDL-C measurements 2. Review concurrent findings for:

   • Abnormal liver chemistries (present in 56.8% of extremely low values)
   • Decreased kidney function (31.2%)
   • Very high triglycerides ≥ 500 mg/dL (33.6%)
   • Elevated CRP
   • Anemia 3

3. Consider preanalytical issues - Delayed serum separation, dilutional effects, or lipemic interference occur in approximately 12% of extremely low HDL-C cases and similar issues affect LDL-C 3

4. If truly extremely low (< 20 mg/dL), consider genetic causes:

   • APOB mutations (most common monogenic cause) 4
   • PCSK9 loss-of-function mutations 5
   • ANGPTL3 deficiency 6
   • Abetalipoproteinemia or familial hypobetalipoproteinemia (if homozygous, causes severe clinical sequelae) 6

Management Approach

For calculation artifacts (negative values):

• Report as "LDL-C < 0.50 mmol/L" or "< 20 mg/dL" with a comment that the value is too low to be accurately estimated 1
• Do NOT report negative numbers
• Consider direct measurement by β-quantification if clinically necessary 5

For true extremely low LDL-C:

• Heterozygous genetic conditions (APOB, PCSK9 deficiency): Generally benign, no treatment needed, protected against cardiovascular disease 4, 6
• Homozygous conditions (abetalipoproteinemia, homozygous hypobetalipoproteinemia): Require early high-dose vitamin therapy (A, D, E, K) and low-fat diet to prevent neurological, ophthalmological, and hematological complications 6
• Secondary causes: Treat underlying condition (malignancy, liver disease, malnutrition, hyperthyroidism) 7

Critical Pitfalls to Avoid

• Do not use Friedewald equation for patients with LDL-C < 1.80 mmol/L (70 mg/dL) or triglycerides > 4.52 mmol/L (400 mg/dL) 1
• Do not confuse direct homogeneous assays with true β-quantification - commercial direct methods are unreliable and not standardized 5
• Do not dismiss extremely low values without investigating for monoclonal paraproteins or severe genetic conditions that require treatment 2, 6
• Do not assume polygenic risk - in one study, no patients with extremely low LDL-C had polygenic risk scores below the 5th percentile 4

The NIH equation should have a mandatory lower reporting limit of 0.50 mmol/L (20 mg/dL), below which values should be reported as "< 0.50 mmol/L" rather than as calculated negative numbers 1.